Vector-borne diseases (VBDs) are a significant public health concern in India, posing a substantial burden on the healthcare system. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, include Malaria, Dengue, Chikungunya, and Japanese Encephalitis, among others.
India, with its tropical climate and high population density, provides an ideal environment for vector proliferation. Malaria, primarily caused by Plasmodium falciparum and Plasmodium vivax, is highly prevalent, with approximately 1.1 million cases reported in 2019. Dengue, another critical VBD, witnessed an alarming surge, with over 157,000 cases in the same year. The prevalence of other VBDs like Chikungunya and Japanese Encephalitis also remains high, contributing to the overall disease burden.
The management of VBDs in India is fraught with challenges. These include inadequate surveillance, limitations in diagnostic facilities, and resistance to vector control measures. Additionally, socio-economic factors such as poor sanitation, lack of awareness, and limited access to healthcare services exacerbate the situation.
Effective management of VBDs requires a multifaceted approach. Early diagnosis and prompt treatment are critical to reducing morbidity and mortality. Strengthening surveillance systems can facilitate early detection and timely intervention. Vector control strategies, including the use of insecticide-treated nets and indoor residual spraying, should be intensified. Importantly, community participation and education are crucial to ensuring the success of these strategies.
Vector-borne diseases pose a significant threat to public health in India. Despite the challenges, comprehensive strategies encompassing surveillance, diagnosis, treatment, vector control, and community participation can substantially mitigate this burden. As healthcare professionals, understanding the prevalence and management of these diseases is vital to improving patient outcomes and public health.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation